Hospitalized COVID-19 Androgenetic Alopecia JAAD data age-range comparison with other references

In this supplement, we compare the dataset of the JAAD Research Letter: Androgenetic alopecia present in the majority of patients hospitalized with COVID-19 - The "Gabrin Sign". (10.1016/j.jaad.2020.05.079), with the main epidemiological data published. Data of patients admitted due to severe COVID-19 in three Madrid hospitals. The study took place from March 23, 2020 to April 12, 2020. Dermatologists recorded the age, gender and alopecia diagnosis. Alopecia severity was evaluated using the Hamilton–Norwood scale (HNS) for males and the Ludwig scale (LS) for females.本补充材料中，我们将《JAAD研究快报：因COVID-19住院的多数患者均存在雄激素性脱发——“Gabrin征”》（DOI: 10.1016/j.jaad.2020.05.079）对应的数据集与已发表的主要流行病学数据进行了对比。本研究数据来源于马德里三家医院收治的重型COVID-19患者，研究开展时间为2020年3月23日至2020年4月12日。皮肤科医师记录了患者的年龄、性别及脱发诊断结果。脱发严重程度分别采用男性适用的汉密尔顿-诺伍德量表（Hamilton–Norwood scale, HNS）与女性适用的路德维希量表（Ludwig scale, LS）进行评估。